Published on 8 Dec 2021 on Insider Monkey via Yahoo Finance

Hedge Funds Are Crazy About United Therapeutics Corporation (UTHR)

In this article you are going to find out whether hedge funds think United Therapeutics Corporation (NASDAQ:UTHR) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk attributes. It's not surprising given that hedge funds have access to better information and more resources to predict the winners in the stock market.

Is United Therapeutics Corporation (NASDAQ:UTHR) a healthy stock for your portfolio? Prominent investors were becoming hopeful. The number of long hedge fund bets moved up by 7 recently. United Therapeutics Corporation (NASDAQ:UTHR) was in 52 hedge funds' portfolios at the end of September. The all time high for this statistic is 45. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. Our calculations also showed that UTHR isn't among the 30 most popular stocks among hedge funds (click for Q3 rankings).

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, lithium prices have more than doubled over the past year, so we go through lists like the 10 best EV stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. With all of this in mind let's review the new hedge fund action encompassing United Therapeutics Corporation (NASDAQ:UTHR).